KP Tissue Inc. (KPTSF)
OTCMKTS
· Delayed Price · Currency is USD
6.53
+0.01 (0.16%)
At close: Jun 4, 2025
KP Tissue Statistics
Total Valuation
KP Tissue has a market cap or net worth of 65.65 million.
Market Cap | 65.65M |
Enterprise Value | n/a |
Important Dates
The last earnings date was Friday, May 9, 2025.
Earnings Date | May 9, 2025 |
Ex-Dividend Date | Mar 31, 2025 |
Share Statistics
Current Share Class | 10.00M |
Shares Outstanding | n/a |
Shares Change (YoY) | +0.23% |
Shares Change (QoQ) | +0.07% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 9.95M |
Valuation Ratios
The trailing PE ratio is 30.95 and the forward PE ratio is 1.59.
PE Ratio | 30.95 |
Forward PE | 1.59 |
PS Ratio | n/a |
PB Ratio | 1.37 |
P/TBV Ratio | 1.37 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.00
Current Ratio | 1.00 |
Quick Ratio | 1.00 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 4.37%.
Return on Equity (ROE) | 4.37% |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | 786 |
Employee Count | 2,700 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +7.05% in the last 52 weeks. The beta is 0.26, so KP Tissue's price volatility has been lower than the market average.
Beta (5Y) | 0.26 |
52-Week Price Change | +7.05% |
50-Day Moving Average | 5.86 |
200-Day Moving Average | 7.18 |
Relative Strength Index (RSI) | 70.63 |
Average Volume (20 Days) | 1,787 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | n/a |
Pretax Income | 2.16M |
Net Income | 2.12M |
EBITDA | n/a |
EBIT | n/a |
Earnings Per Share (EPS) | 0.21 |
Balance Sheet
Cash & Cash Equivalents | n/a |
Total Debt | n/a |
Net Cash | n/a |
Net Cash Per Share | n/a |
Equity (Book Value) | 47.97M |
Book Value Per Share | 4.80 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.52, which amounts to a dividend yield of 7.92%.
Dividend Per Share | 0.52 |
Dividend Yield | 7.92% |
Dividend Growth (YoY) | -3.05% |
Years of Dividend Growth | n/a |
Payout Ratio | 228.47% |
Buyback Yield | -0.23% |
Shareholder Yield | 7.69% |
Earnings Yield | 3.23% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |